Qiming U.S. Ventures Management, LLC Hille Vax, Inc. Transaction History
Qiming U.S. Ventures Management, LLC
- $1.66 Million
- Q4 2024
A detailed history of Qiming U.S. Ventures Management, LLC transactions in Hille Vax, Inc. stock. As of the latest transaction made, Qiming U.S. Ventures Management, LLC holds 372,615 shares of HLVX stock, worth $648,350. This represents 45.73% of its overall portfolio holdings.
Number of Shares
372,615
Previous 558,923
33.33%
Holding current value
$648,350
Previous $983,000
22.69%
% of portfolio
45.73%
Previous 39.02%
Shares
2 transactions
Others Institutions Holding HLVX
# of Institutions
78Shares Held
36.1MCall Options Held
0Put Options Held
0-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.6MShares$18.5 Million1.01% of portfolio
-
Tang Capital Management LLC San Diego, CA4.92MShares$8.56 Million0.74% of portfolio
-
Black Rock Inc. New York, NY2.09MShares$3.64 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA1.96MShares$3.41 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.88MShares$3.28 Million0.06% of portfolio
About HilleVax, Inc.
- Ticker HLVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,427,200
- Market Cap $58.2M
- Description
- HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.